Abstract:Background: The important role of nucleobindin 2 (NUCB2) in various cancers has been recently recognized. However, its biological functions and regulatory mechanisms in hepatocellular carcinoma (HCC) remain unclear. Methods: The expression level of NUCB2 in HCC was assessed using public databases, immunohistochemistry, and Western blotting. The effects of NUCB2 on cell proliferation and metastasis were investigated using colony formation, EdU, Transwell assays, and an in vivo mouse xenograft model. Regulation of E2F4 by NUCB2 was identified by protein half-life and in vivo ubiquitylation assays. The relationship between E2F4 and prostaglandin reductase 1 (PTGR1) was investigated by qRT-PCR, RT-PCR, and chromatin immunoprecipitation assays. Results: This study found that NUCB2 expression was significantly higher in HCC tissues than in normal liver tissues, and patients with high expression displayed shorter survival rates. Inhibition of NUCB2 reduced the proliferation and metastatic potential of HCC cells in vitro and in vivo. NUCB2 depletion reduced PTGR1 expression, which reduced cell proliferation and migration. Our findings suggested that NUCB2 suppressed E2F4 degradation by interacting with E2F4. Additionally, increased E2F4 levels facilitated PTGR1 transcription by directly binding to the PTGR1 promoter. Conclusion: This study demonstrated the oncogenic properties of NUCB2 in HCC and suggested that NUCB2 facilitates hepatocellular carcinoma progression by activating the E2F4/PTGR1 axis.

Supplemental Figure 2 from Unconjugated Bilirubin is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis Via Antioxidation Activity

Supplementary Figures 1-2 from Serglycin is a Theranostic Target in Nasopharyngeal Carcinoma That Promotes Metastasis

Supplementary Tables 1-3 from Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis

Supplementary Figure S2 from Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Supplemental Figure 8 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplemental Figure 2 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Supplementary Figure 5 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 7 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 6 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

[The prognostic significance and therapeutic prospects of bilirubin in tumors]

Supplementary Figure 5 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Supplementary Figure 4 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Supplementary Figure S12 from CD24hiCD27+ Bregs Within Metastatic Lymph Nodes Promote Multidrug Resistance in Breast Cancer

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis

Supplementary Figure 4 from E2F8 Contributes to Human Hepatocellular Carcinoma Via Regulating Cell Proliferation

Cucurbitacin B as a Chinese Medicine Monomer Inhibits Cell Proliferation, Invasion, and Migration in Nasopharyngeal Carcinoma